Clinical Trial Update: Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial evaluated the combination of oblimersen and doxorubicin in patients with advanced hepatocellular carcinoma (liver cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Doxorubicin (Adriamycin) (doxorubicin)
• Genasense (oblimersen)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED